Literature DB >> 3899818

The influence of insulin antibody levels on the plasma profiles and action of subcutaneously injected human and bovine short acting insulins.

A J Francis, I Hanning, K G Alberti.   

Abstract

The influence of moderate and low insulin antibody levels on insulin absorption and plasma free insulin profiles is uncertain. Two groups of six C-peptide negative diabetic patients, one with low (3.8 +/- 0.8 mu/l) and one with moderate (16.4 +/- 2.0 micrograms/l) serum insulin antibody levels, were studied. Subjects were given 0.3 U/kg neutral human or acid bovine soluble insulin subcutaneously in random order before breakfast on separate days. Moderate antibody levels significantly blunted the rise in plasma free insulin that followed injection of the human and bovine insulins (p less than 0.05). The rise in blood glucose after breakfast was significantly greater in patients with moderate antibody levels (p less than 0.05) and more marked following the bovine than the human insulin (p less than 0.05). Plasma free insulin, blood glucose and 3-hydroxybutyrate profiles suggest that acid bovine soluble insulin has a significantly more protracted action than neutral human insulin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3899818     DOI: 10.1007/bf00283138

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  12 in total

1.  The clinical significance of insulin antibodies.

Authors:  O O Andersen; J Egeberg
Journal:  Acta Paediatr Scand Suppl       Date:  1977

2.  A simple method for the determination of serum free insulin levels in insulin-treated patients.

Authors:  S Nakagawa; H Nakayama; T Sasaki; K Yoshino; Y Y Yu
Journal:  Diabetes       Date:  1973-08       Impact factor: 9.461

3.  Critical variables in the radioimmunoassay of serum insulin using the double antibody technic.

Authors:  J S Soeldner; D Slone
Journal:  Diabetes       Date:  1965-12       Impact factor: 9.461

4.  An immunochemical method for the quantitation of insulin antibodies.

Authors:  W G Reeves; U Kelly
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

Authors:  V A Koivisto; P Felig
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

6.  Role of residual insulin secretion in protecting against ketoacidosis in insulin-dependent diabetes.

Authors:  S Madsbad; K G Alberti; C Binder; J M Burrin; O K Faber; T Krarup; L Regeur
Journal:  Br Med J       Date:  1979-11-17

7.  Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic children.

Authors:  A L Kinmonth; J D Baum
Journal:  Br Med J       Date:  1980-03-01

8.  Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.

Authors:  M Berger; H J Cüppers; H Hegner; V Jörgens; P Berchtold
Journal:  Diabetes Care       Date:  1982 Mar-Apr       Impact factor: 19.112

9.  The bioavailability of circulating antibody-bound insulin following insulin withdrawal in Type 1 (insulin-dependent) diabetes.

Authors:  N J Vaughan; J A Matthews; A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Insulin-induced lipoatrophy: evidence for an immune pathogenesis.

Authors:  W G Reeves; B R Allen; R B Tattersall
Journal:  Br Med J       Date:  1980-06-21
View more
  6 in total

1.  Human insulin.

Authors:  J Pickup
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-18

2.  Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies.

Authors:  Tie-Yun Zhao; Fang Li; Zhong-Yun Xiong
Journal:  Mol Diagn Ther       Date:  2010-08-01       Impact factor: 4.074

Review 3.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

4.  Comparison of the prevalence of islet autoantibodies according to age and disease duration in patients with type 1 diabetes mellitus.

Authors:  Young Hwa Kong; Min Sun Kim; Dae-Yeol Lee
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-06-30

5.  The association between anti-insulin aspart antibodies and the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in children and adolescents with type 1 diabetes.

Authors:  Torben Biester; Thekla von dem Berge; Line Quist Bendtsen; Mette Dahl Bendtsen; Naveen Rathor; Thomas Danne; Hanne Haahr
Journal:  Pediatr Diabetes       Date:  2020-05-05       Impact factor: 4.866

6.  Recurrent hypoglycaemia in type-1 diabetes mellitus may unravel the association with Addison's disease: a case report.

Authors:  Stefano Passanisi; Tiziana Timpanaro; Donatella Lo Presti; Manuela Caruso-Nicoletti
Journal:  BMC Res Notes       Date:  2014-09-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.